Pihlajalinna Oyj

Equities

PIHLIS

FI4000092556

Healthcare Facilities & Services

Market Closed - Nasdaq Helsinki Other stock markets 10:15:57 2024-05-17 am EDT			5-day change	1st Jan Change
9.12 ^EUR	-0.22%		-0.65%	+29.18%

May. 03	Pihlajalinna Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 30	Pihlajalinna Oyj Revises Earnings Guidance for the Year 2024	CI

Pihlajalinna Oyj Revises Earnings Guidance for the Year 2024

April 30, 2024 at 07:30 am EDT

Pihlajalinna Oyj revised earnings guidance for the year 2024. The Group expects the consolidated revenue to decrease from the previous year's level (EUR 720.0 million in 2023) against previous guidance of consolidated revenue to increase from the previous year's level (EUR 720.0 million in 2023).

Latest news about Pihlajalinna Oyj

Pihlajalinna Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 03	CI
Pihlajalinna Oyj Revises Earnings Guidance for the Year 2024	Apr. 30	CI
Pihlajalinna plc announces Changes in Management Team	Apr. 16	CI
Pihlajalinna plc Approves Dividend for the Year 2023, Payable on April 19, 2024	Apr. 10	CI
Pihlajalinna plc Announces Board Committee Appointments	Apr. 10	CI
Pihlajalinna Oyj announces an Equity Buyback for 150,000 shares, representing 0.66% for ?1.3 million.	Mar. 26	CI
Pihlajalinna Oyj authorizes a Buyback Plan.	Mar. 25	CI
Pihlajalinna Oyj Proposes Dividend for Financial Year That Ended on 31 December 2023, Payable on 19 April 2024	Mar. 14	CI
Antti-Jussi Aro Decides to Leave Pihlajalinna plc as Chief Information Officer, Effective 10 May 2024	Mar. 05	CI
Finland's Pihlajalinna COO Plans February-end Exit	Feb. 14	MT
Pihlajalinna plc Announces Resignation of Timo Harju as Chief Operating Officer, Private Health Services, Effective 29 February 2024	Feb. 14	CI
Pihlajalinna Oyj Proposes Dividend for the Financial Year Ended on 31 December 2023, Payable on April 19, 2024	Feb. 14	CI
Pihlajalinna Oyj Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 14	CI
Pihlajalinna Plc Provides Earnings Guidance for the Year 2023	Jan. 24	CI
Pihlajalinna Oyj Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 03	CI
Pihlajalinna Oyj Reaffirms Revenue Guidance for 2023	Nov. 03	CI
Pihlajalinna's Complete Outsourcing Agreement in the Wellness Services County of South Ostrobothnia Will End in 2025	23-10-30	CI
Pihlajalinna plc and Fennia Deepen the Partnership and Sign a New Co-Operation Agreement	23-09-18	CI
Pihlajalinna Oyj Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Pihlajalinna Oyj Provides Consolidated Revenue Guidance for the Year 2023	23-08-11	CI
Pihlajalinna Announces Appointment of Tuomas Hyyryläinen as the CEO, Effective 1 September 2023	23-06-06	CI
Finland's Pihlajalinna Names Fiskars Executive as CEO	23-04-28	MT
Pihlajalinna Oyj Appoints Tuomas Hyyryläinen as CEO	23-04-28	CI
Pihlajalinna Oyj Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Pihlajalinna Oyj Provides Consolidated Revenue Guidance for 2023	23-04-28	CI

Chart Pihlajalinna Oyj

Duration

Period

More charts

Company Profile

Pihlajalinna Oyj is a Finland-based company providing social and healthcare services. It dedicates its offer to individuals, businesses and public institutions. It operates medical and health centers, dental clinics and hospitals around Finland. The Company operates in two segments: Private Clinics and Specialized Care (L&E), which includes medical centers, surgical operations, public specialized care, dental healthcare and occupational health services; and Primary and Social Care (P&S), which comprises social care, outsourcing of healthcare, health packages, and employment services. The Company's activities are conducted under two brands, namely Pihlajalinna and Dextra. Also, it offers wellbeing services through the Forever fitness centre chain.

Sector

Healthcare Facilities & Services

Calendar

2024-08-09 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Pihlajalinna Oyj

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.12 EUR

Average target price

9.225 EUR

Spread / Average Target

+1.15%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
PIHLAJALINNA OYJ	+29.18%	223M
HCA HEALTHCARE, INC.	+19.28%	84.56B
CVS HEALTH CORPORATION	-26.95%	72.41B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+4.65%	27.75B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-7.35%	17.75B
QUEST DIAGNOSTICS INCORPORATED	+4.69%	16.03B
REDE D'OR SÃO LUIZ S.A.	+8.14%	13.72B
NATERA, INC.	+69.96%	13.07B
FRESENIUS MEDICAL CARE AG	+6.59%	12.91B
TENET HEALTHCARE CORPORATION	+70.00%	12.55B

Other Healthcare Facilities & Services